{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T00:12:46Z","timestamp":1792541566263,"version":"4.5.0"},"reference-count":88,"publisher":"American Society of Hematology","issue":"1","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2014,12,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>As medical advances improve survival, reduce disease-related morbidity, and improve quality of life, reproductive issues will take higher priority in the sickle cell disease (SCD) community. A wide variety of topics are addressed in this chapter, including fertility, gonadal failure, erectile dysfunction, and menstrual issues in SCD. Etiologies of impaired male fertility are multifactorial and include hypogonadism, erectile dysfunction, sperm abnormalities, and complications of medical therapies. Much less is known about the prevalence and etiology of infertility in women with SCD. Other reproductive issues in women included in this review are pain and the menstrual cycle, contraception, and preconception counseling. Finally, long-term therapies for SCD and their impact on fertility are presented. Transfusional iron overload and gonadal failure are addressed, followed by options for fertility preservation after stem cell transplantation. Focus is placed on hydroxyurea therapy given its benefits and increasing use in SCD. The impact of this agent on spermatogenesis, azoospermia, and the developing fetus is discussed.<\/jats:p>","DOI":"10.1182\/asheducation-2014.1.418","type":"journal-article","created":{"date-parts":[[2014,11,24]],"date-time":"2014-11-24T18:39:03Z","timestamp":1416854343000},"page":"418-424","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":38,"title":["Reproductive issues in sickle cell disease"],"prefix":"10.1182","volume":"2014","author":[{"given":"Kim","family":"Smith-Whitley","sequence":"first","affiliation":[{"name":"Division of Hematology, The Children's Hospital of Philadelphia, Philadelphia, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"1","key":"2019111705204081700_B1","first-page":"61","article-title":"Growth and development in sickle cell anemia: preliminary report","volume":"4","author":"Luban","year":"1982","journal-title":"Am J Pediatr Hematol Oncol"},{"issue":"5 Pt 1","key":"2019111705204081700_B2","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1203\/pdr.0b013e318045bdca","article-title":"Effects of delayed pubertal development, nutritional status, and disease severity on longitudinal patterns of growth failure in children with sickle cell disease","volume":"61","author":"Zemel","year":"2007","journal-title":"Pediatr Res"},{"issue":"2","key":"2019111705204081700_B3","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1159\/000337344","article-title":"Hypogonadism in patients with sickle cell disease: central or peripheral?","volume":"128","author":"Taddesse","year":"2012","journal-title":"Acta Haematol"},{"issue":"2","key":"2019111705204081700_B4","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/0009-8981(80)90469-6","article-title":"Endocrine function and haemoglobinopathies: relation between the sickle cell gene and circulating plasma levels of testosterone, luteinising hormone (LH) and follicle stimulating hormone (FSH) in adult males","volume":"105","author":"Dada","year":"1980","journal-title":"Clin Chim Acta"},{"issue":"736","key":"2019111705204081700_B5","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1136\/pgmj.63.736.95","article-title":"Testicular dysfunction in men with sickle cell disease","volume":"63","author":"Osegbe","year":"1987","journal-title":"Postgrad Med J"},{"issue":"1","key":"2019111705204081700_B6","first-page":"12","article-title":"The mechanism of low testosterone levels in homozygous sickle-cell disease","volume":"43","author":"Parshad","year":"1994","journal-title":"West Indian Med J"},{"issue":"5","key":"2019111705204081700_B7","doi-asserted-by":"crossref","first-page":"601","DOI":"10.7326\/0003-4819-85-5-601","article-title":"Gonadal function abnormalities in sickle cell anemia: studies in adult male patients","volume":"85","author":"Abbasi","year":"1976","journal-title":"Ann Intern Med"},{"issue":"6","key":"2019111705204081700_B8","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1093\/tropej\/38.6.307","article-title":"Endocrine functions in sickle cell anaemia patients","volume":"38","author":"el-Hazmi","year":"1992","journal-title":"J Trop Pediatr"},{"issue":"4","key":"2019111705204081700_B9","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/S0015-0282(16)57500-1","article-title":"Effect of age on testicular function in adult males with sickle cell anemia","volume":"63","author":"Modebe","year":"1995","journal-title":"Fertil Steril"},{"key":"2019111705204081700_B10","first-page":"165","article-title":"Zinc deficiency in human subjects","volume":"77","author":"Prasad","year":"1981","journal-title":"Prog Clin Biol Res"},{"issue":"3","key":"2019111705204081700_B11","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/S0090-4295(03)00482-5","article-title":"Repeated testicular infarction in a patient with sickle cell disease: a possible mechanism for testicular failure","volume":"62","author":"Li","year":"2003","journal-title":"Urology"},{"issue":"4","key":"2019111705204081700_B12","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1111\/j.2047-2927.2013.00084.x","article-title":"Testosterone replacement therapy does not promote priapism in hypogonadal men with sickle cell disease: 12-month safety report","volume":"1","author":"Morrison","year":"2013","journal-title":"Andrology"},{"issue":"4","key":"2019111705204081700_B13","doi-asserted-by":"crossref","first-page":"480","DOI":"10.7326\/0003-4819-99-4-480","article-title":"Clomiphene-responsive hypogonadism in sickle cell anemia","volume":"99","author":"Landefeld","year":"1983","journal-title":"Ann Intern Med"},{"issue":"7","key":"2019111705204081700_B14","doi-asserted-by":"crossref","first-page":"988","DOI":"10.3324\/haematol.11515","article-title":"Influence of sickle cell disease and treatment with hydroxyurea on sperm parameters and fertility of human males","volume":"93","author":"Berthaut","year":"2008","journal-title":"Haematologica"},{"issue":"6","key":"2019111705204081700_B15","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1111\/j.1439-0272.1980.tb01347.x","article-title":"Semen analysis in sickle cell disease","volume":"12","author":"Nahoum","year":"1980","journal-title":"Andrologia"},{"issue":"8241","key":"2019111705204081700_B16","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0140-6736(81)90525-0","article-title":"Fertility in males with sickle cell disease","volume":"ii","author":"Osegbe","year":"1981","journal-title":"Lancet"},{"issue":"12","key":"2019111705204081700_B17","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/S0015-0282(16)40809-5","article-title":"Testicular function in sickle cell disease","volume":"25","author":"Friedman","year":"1974","journal-title":"Fertil Steril"},{"issue":"9","key":"2019111705204081700_B18","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1046\/j.1464-410X.2002.03022.x","article-title":"Priapism in sickle-cell disease; incidence, risk factors and complications-an international multicentre study","volume":"90","author":"Adeyoju","year":"2002","journal-title":"BJU Int"},{"issue":"11","key":"2019111705204081700_B19","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1001\/archinte.1980.00330220022011","article-title":"Priapism and impotence in homozygous sickle cell disease","volume":"140","author":"Emond","year":"1980","journal-title":"Arch Intern Med"},{"issue":"3","key":"2019111705204081700_B20","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1159\/000360608","article-title":"Priapism in homozygous sickle cell patients: important clinical and laboratory associations","volume":"23","author":"Madu","year":"2014","journal-title":"Med Princ Pract"},{"issue":"4","key":"2019111705204081700_B21","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/0090-4295(85)90176-1","article-title":"Implantation of penile prostheses in patients impotent after priapism","volume":"26","author":"Bertram","year":"1985","journal-title":"Urology"},{"issue":"5","key":"2019111705204081700_B22","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1111\/j.1464-410X.1990.tb14803.x","article-title":"Penile prostheses in the management of impotence in sickle cell disease","volume":"65","author":"Douglas","year":"1990","journal-title":"Br J Urol"},{"issue":"5","key":"2019111705204081700_B23","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1001\/archpedi.1966.02090080075005","article-title":"Studies in sickle cell anemia XXVI. The effect of homozygous sickle cell disease in the onset of menarche, pregnancy, fertility, pubescent changes and body growth in Negro subjects","volume":"111","author":"Jimenez","year":"1966","journal-title":"Am J Dis Child"},{"issue":"10","key":"2019111705204081700_B24","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1001\/archinte.1981.00340100051014","article-title":"Sexual development and fertility of Jamaican female patients with homozygous sickle cell disease","volume":"141","author":"Alleyne","year":"1981","journal-title":"Arch Intern Med"},{"issue":"8","key":"2019111705204081700_B25","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/S0015-0282(16)37688-9","article-title":"Fertility in hemoglobin S-S and hemoglobin S-C disease","volume":"21","author":"Dunne","year":"1970","journal-title":"Fertil Steril"},{"issue":"9","key":"2019111705204081700_B26","first-page":"879","article-title":"Contraceptive practices and reproductive patterns in sickle cell disease","volume":"76","author":"Samuels-Reid","year":"1984","journal-title":"J Natl Med Assoc"},{"issue":"4","key":"2019111705204081700_B27","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1097\/00007611-198504000-00007","article-title":"Painful crises and menstruation in sickle cell disease","volume":"78","author":"Samuels-Reid","year":"1985","journal-title":"South Med J"},{"issue":"3","key":"2019111705204081700_B28","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/(SICI)1096-8652(199703)54:3<183::AID-AJH2>3.0.CO;2-S","article-title":"Assessment of painful episode frequency in sickle-cell disease","volume":"54","author":"Westerman","year":"1997","journal-title":"Am J Hematol"},{"issue":"4","key":"2019111705204081700_B29","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1080\/01443610220141362","article-title":"Menstrual pattern in women with sickle cell anaemia and its association with sickling crises","volume":"22","author":"Yoong","year":"2002","journal-title":"J Obstet Gynaecol"},{"issue":"7750","key":"2019111705204081700_B30","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/S0140-6736(72)90359-5","article-title":"Steroid treatment in the prevention of painful episodes in sickle-cell disease","volume":"i","author":"Isaacs","year":"1972","journal-title":"Lancet"},{"issue":"2","key":"2019111705204081700_B31","first-page":"113","article-title":"Sexuality and sickle cell disease","volume":"85","author":"Chavis","year":"1993","journal-title":"J Natl Med Assoc"},{"issue":"2","key":"2019111705204081700_B32","doi-asserted-by":"crossref","first-page":"89","DOI":"10.5581\/1516-8484.20130027","article-title":"Sexuality and sickle cell anemia","volume":"35","author":"C\u00f4bo","year":"2013","journal-title":"Rev Bras Hematol Hemoter"},{"issue":"9","key":"2019111705204081700_B33","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1080\/00981389.2012.693580","article-title":"Reproductive attitudes and behaviors in people with sickle cell disease or sickle cell trait: a qualitative interpretive emeta-synthesis","volume":"51","author":"Smith","year":"2012","journal-title":"Soc Work Health Care"},{"issue":"2","key":"2019111705204081700_B34","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.pop.2014.02.004","article-title":"Prevention of unintended pregnancy: a focus on long-acting reversible contraception","volume":"41","author":"Pickle","year":"2014","journal-title":"Prim Care"},{"issue":"9","key":"2019111705204081700_B35","first-page":"879","article-title":"Contraceptive practices and reproductive patterns in sickle cell disease","volume":"76","author":"Samuels-Reid","year":"1984","journal-title":"J Natl Med Assoc"},{"issue":"6894","key":"2019111705204081700_B36","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1136\/bmj.306.6894.1735","article-title":"Contraceptives, counselling, and pregnancy in women with sickle cell disease","volume":"306","author":"Howard","year":"1993","journal-title":"BMJ"},{"issue":"5","key":"2019111705204081700_B37","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.contraception.2009.05.121","article-title":"Contraceptive usage among Jamaican women with sickle cell disease","volume":"80","author":"Knight-Madden","year":"2009","journal-title":"Contraception"},{"issue":"2","key":"2019111705204081700_B38","doi-asserted-by":"crossref","first-page":"171","DOI":"10.3109\/01443610903452799","article-title":"Pattern of contraceptive use among women with sickle cell disease in Ibadan, South-west Nigeria","volume":"30","author":"Okunlola","year":"2010","journal-title":"J Obstet Gynaecol"},{"issue":"2","key":"2019111705204081700_B39","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.contraception.2010.06.017","article-title":"Hormonal contraception use and pregnancy in adolescents with sickle cell disease: analysis of Michigan Medicaid claims","volume":"83","author":"O'Brien","year":"2011","journal-title":"Contraception"},{"key":"2019111705204081700_B40","article-title":"Trends in family planning and counselling for women with sickle cell disease in the UK over two decades [published online ahead of print May 23, 2014]","author":"Eissa","journal-title":"J Fam Plann Reprod Health Care"},{"issue":"3","key":"2019111705204081700_B41","doi-asserted-by":"crossref","first-page":"211","DOI":"10.3109\/00016348309155794","article-title":"Sickle cell diseases and hormonal contraception","volume":"62","author":"Freie","year":"1983","journal-title":"Acta Obstet Gynecol Scand"},{"key":"2019111705204081700_B42","first-page":"863A","article-title":"A lack of morbidity from oral contraception in women with sickle cell anemia [abstract]","volume":"29","author":"Lutcher","year":"1981","journal-title":"Clin Res"},{"key":"2019111705204081700_B43","first-page":"217A","article-title":"Contraceptive-induced vascular occlusive events in sickle cell disorders-fact or fiction? [abstract]","volume":"34","author":"Lutcher","year":"1986","journal-title":"Clin Res"},{"issue":"5","key":"2019111705204081700_B44","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0010-7824(97)00156-X","article-title":"Effect of Depo-Provera or Microgynon on the painful crises of sickle cell anemia patients","volume":"56","author":"de Abood","year":"1997","journal-title":"Contraception"},{"issue":"8292","key":"2019111705204081700_B45","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0140-6736(82)90320-8","article-title":"Medroxyprogesterone acetate and homozygous sickle-cell disease","volume":"ii","author":"De Ceulaer","year":"1982","journal-title":"Lancet"},{"issue":"5","key":"2019111705204081700_B46","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0010-7824(01)00202-5","article-title":"Carbohydrate metabolism in sickle cell patients using a subdermal implant containing nomegestrol acetate (Uniplant)","volume":"63","author":"Barbosa","year":"2001","journal-title":"Contraception"},{"issue":"4","key":"2019111705204081700_B47","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/S0009-9236(98)90074-1","article-title":"Nomegestrol acetate contraceptive implant use by women with sickle cell disease","volume":"64","author":"Nascimento","year":"1998","journal-title":"Clin Pharmacol Ther"},{"issue":"6","key":"2019111705204081700_B48","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1097\/00006250-200606000-00055","article-title":"ACOG practice bulletin. No. 73: Use of hormonal contraception in women with coexisting medical conditions","volume":"107","author":"ACOG Committee on Practice Bulletins-Gynecology","year":"2006","journal-title":"Obstet Gynecol"},{"issue":"RR-4","key":"2019111705204081700_B49","first-page":"1","article-title":"U.S. Medical Eligibility Criteria for Contraceptive Use, 2010","volume":"59","author":"Centers for Disease Control and Prevention","year":"2010","journal-title":"MMWR Recomm Rep"},{"issue":"7","key":"2019111705204081700_B50","doi-asserted-by":"crossref","first-page":"675","DOI":"10.2174\/156652408786241393","article-title":"Recent advances in bone marrow transplantation in hemoglobinopathies","volume":"8","author":"Michlitsch","year":"2008","journal-title":"Curr Mol Med"},{"issue":"2","key":"2019111705204081700_B51","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/sj.bmt.1705943","article-title":"Hematopoietic cell transplantation for thalassemia and sickle cell disease: past, present and future","volume":"41","author":"Bhatia","year":"2008","journal-title":"Bone Marrow Transplant"},{"key":"2019111705204081700_B52","article-title":"Hematopoietic SCT for the Black African and non-Black African variants of sickle cell anemia [published online ahead of print July 28, 2014]","author":"Lucarelli","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"2019111705204081700_B53","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.bbmt.2009.10.005","article-title":"Pulmonary, gonadal, and central nervous system status after bone marrow transplantation for sickle cell disease","volume":"16","author":"Walters","year":"2010","journal-title":"Biol Blood Marrow Transplant"},{"issue":"6","key":"2019111705204081700_B54","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1093\/humrep\/der089","article-title":"Live birth after allografting of ovarian cortex between genetically non-identical sisters","volume":"26","author":"Donnez","year":"2011","journal-title":"Hum Reprod"},{"issue":"24","key":"2019111705204081700_B55","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1056\/NEJMoa0904971","article-title":"Allogeneic hematopoietic stem-cell transplantation for sickle cell disease","volume":"361","author":"Hsieh","year":"2009","journal-title":"N Engl J Med"},{"issue":"1","key":"2019111705204081700_B56","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1001\/jama.2014.7192","article-title":"Nonmyeloablative HLA-matched sibling allogeneic hematopoietic stem cell transplantation for severe sickle cell phenotype","volume":"312","author":"Hsieh","year":"2014","journal-title":"JAMA"},{"issue":"11","key":"2019111705204081700_B57","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1016\/j.bbmt.2008.08.016","article-title":"Stable long-term donor engraftment following reduced-intensity hematopoietic cell transplantation for sickle cell disease","volume":"14","author":"Krishnamurti","year":"2008","journal-title":"Biol Blood Marrow Transplant"},{"issue":"1","key":"2019111705204081700_B58","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.pcl.2010.01.003","article-title":"Hematopoietic stem cell transplantation for hemoglobinopathies: current practice and emerging trends","volume":"57","author":"Smiers","year":"2010","journal-title":"Pediatr Clin North Am"},{"issue":"9","key":"2019111705204081700_B59","doi-asserted-by":"crossref","first-page":"e157","DOI":"10.4158\/EP13474.CR","article-title":"Successful fertility restoration after allogeneic hematopoietic stem cell transplantation","volume":"20","author":"Gharwan","year":"2014","journal-title":"Endocr Pract"},{"issue":"3","key":"2019111705204081700_B60","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s10815-011-9698-2","article-title":"Oocyte cryopreservation in a patient with sickle cell disease prior to hematopoietic stem cell transplantation: first report","volume":"29","author":"Dovey","year":"2012","journal-title":"J Assist Reprod Genet"},{"issue":"7","key":"2019111705204081700_B61","doi-asserted-by":"crossref","first-page":"2413.e15","DOI":"10.1016\/j.fertnstert.2009.12.022","article-title":"Live birth after ovarian tissue autograft in a patient with sickle cell disease treated by allogeneic bone marrow transplantation","volume":"93","author":"Roux","year":"2010","journal-title":"Fertil Steril"},{"issue":"6","key":"2019111705204081700_B62","doi-asserted-by":"crossref","first-page":"437","DOI":"10.3109\/07853890.2010.546807","article-title":"Children born after autotransplantation of cryopreserved ovarian tissue. a review of 13 live births","volume":"43","author":"Donnez","year":"2011","journal-title":"Ann Med"},{"issue":"9","key":"2019111705204081700_B63","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1002\/pbc.25078","article-title":"Testicular tissue cryopreservation in prepubertal male children: an analysis of parental decision-making","volume":"61","author":"Ginsberg","year":"2014","journal-title":"Pediatr Blood Cancer"},{"issue":"6","key":"2019111705204081700_B64","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1093\/humupd\/dmq010","article-title":"Fertility preservation in girls during childhood: is it feasible, efficient and safe and to whom should it be proposed?","volume":"16","author":"Jadoul","year":"2010","journal-title":"Hum Reprod Update"},{"issue":"1","key":"2019111705204081700_B65","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.fertnstert.2012.09.028","article-title":"Mature oocyte cryopreservation: a guideline","volume":"99","author":"Practice Committees of American Society for Reproductive Medicine; Society for Assisted Reproductive Technology","year":"2013","journal-title":"Fertil Steril"},{"issue":"5","key":"2019111705204081700_B66","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1016\/j.fertnstert.2014.02.052","article-title":"Ovarian tissue cryopreservation: a committee opinion","volume":"101","author":"Practice Committee of American Society for Reproductive Medicine","year":"2014","journal-title":"Fertil Steril"},{"key":"2019111705204081700_B67","article-title":"Risk of thrombosis in women with malignancies undergoing ovarian stimulation for fertility preservation [published online ahead of print July 10, 2014]","author":"Somigliana","journal-title":"Hum Reprod Update"},{"issue":"6","key":"2019111705204081700_B68","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1080\/15265161.2012.673688","article-title":"Preserving the right to future children: an ethical case analysis","volume":"12","author":"Quinn","year":"2012","journal-title":"Am J Bioeth"},{"issue":"4","key":"2019111705204081700_B69","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1002\/ajh.20809","article-title":"Morbidity and mortality in chronically transfused subjects with thalassemia and sickle cell disease: a report from the multi-center study of iron overload","volume":"82","author":"Fung","year":"2007","journal-title":"Am J Hematol"},{"issue":"4","key":"2019111705204081700_B70","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1111\/j.1365-2141.2006.06332.x","article-title":"Increased prevalence of iron-overload associated endocrinopathy in thalassaemia versus sickle-cell disease","volume":"135","author":"Fung","year":"2006","journal-title":"Br J Haematol"},{"issue":"10","key":"2019111705204081700_B71","doi-asserted-by":"crossref","first-page":"2878","DOI":"10.1182\/blood-2011-06-360271","article-title":"Reproductive capacity in iron overloaded women with thalassemia major","volume":"118","author":"Singer","year":"2011","journal-title":"Blood"},{"issue":"20","key":"2019111705204081700_B72","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1056\/NEJM199505183322001","article-title":"Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia","volume":"332","author":"Charache","year":"1995","journal-title":"N Engl J Med"},{"issue":"4","key":"2019111705204081700_B73","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1097\/00043426-199707000-00009","article-title":"Three-year follow-up of hydroxyurea treatment in severely ill children with sickle cell disease. The French Study Group on Sickle Cell Disease","volume":"19","author":"de Montalembert","year":"1997","journal-title":"J Pediatr Hematol Oncol"},{"issue":"9778","key":"2019111705204081700_B74","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1016\/S0140-6736(11)60355-3","article-title":"Hydroxycarbamide in very young children with sickle-cell anaemia: a multicentre, randomised, controlled trial (BABY HUG)","volume":"377","author":"Wang","year":"2011","journal-title":"Lancet"},{"issue":"2","key":"2019111705204081700_B75","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1067\/mpd.2002.121383","article-title":"Effect of hydroxyurea on growth in children with sickle cell anemia: results of the HUG-KIDS Study","volume":"140","author":"Wang","year":"2002","journal-title":"J Pediatr"},{"key":"2019111705204081700_B76","first-page":"vii","article-title":"NTP-CERHR monograph on the potential human reproductive and developmental effects of hydroxyurea","volume":"21","author":"National Toxicology Program","year":"2008","journal-title":"NTP CERHR Mon"},{"issue":"6","key":"2019111705204081700_B77","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1542\/peds.2008-0441","article-title":"Hydroxyurea for sickle cell disease: a systematic review for efficacy and toxicity in children","volume":"122","author":"Strouse","year":"2008","journal-title":"Pediatrics"},{"issue":"12","key":"2019111705204081700_B78","doi-asserted-by":"crossref","first-page":"939","DOI":"10.7326\/0003-4819-148-12-200806170-00221","article-title":"Systematic review: Hydroxyurea for the treatment of adults with sickle cell disease","volume":"148","author":"Lanzkron","year":"2008","journal-title":"Ann Intern Med"},{"issue":"2","key":"2019111705204081700_B79","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1006\/taap.1998.8593","article-title":"Involvement of germ cell apoptosis in the induction of testicular toxicity following hydroxyurea treatment","volume":"155","author":"Shin","year":"1999","journal-title":"Toxicol Appl Pharmacol"},{"issue":"3","key":"2019111705204081700_B80","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.3390\/ijerph6031124","article-title":"Adverse effects of a clinically relevant dose of hydroxyurea used for the treatment of sickle cell disease on male fertility end points","volume":"6","author":"Jones","year":"2009","journal-title":"Int J Environ Res Public Health"},{"issue":"11","key":"2019111705204081700_B81","first-page":"1216","article-title":"Azoospermia in a patient with sickle cell disease treated with hydroxyurea","volume":"85","author":"Garozzo","year":"2000","journal-title":"Haematologica"},{"issue":"3","key":"2019111705204081700_B82","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1111\/j.1445-5994.2006.01290.x","article-title":"Effect of hydroxyurea on sperm count, motility and morphology in adult men with sickle cell or myeloproliferative disease","volume":"37","author":"Grigg","year":"2007","journal-title":"Intern Med J"},{"issue":"11","key":"2019111705204081700_B83","doi-asserted-by":"crossref","first-page":"e67","DOI":"10.3324\/haematol.13659","article-title":"Use of hydroxyurea from childhood to adult age in sickle cell disease: semen analysis","volume":"93","author":"Lukusa","year":"2008","journal-title":"Haematologica"},{"issue":"4","key":"2019111705204081700_B84","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1080\/07357900902892780","article-title":"Bone marrow transplantation or hydroxyurea for sickle cell anemia: long-term effects on semen variables and hormone profiles","volume":"26","author":"Lukusa","year":"2009","journal-title":"Pediatr Hematol Oncol"},{"issue":"12","key":"2019111705204081700_B85","doi-asserted-by":"crossref","first-page":"932","DOI":"10.7326\/0003-4819-148-12-200806170-00220","article-title":"National Institutes of Health Consensus Development Conference Statement: hydroxyurea treatment for sickle cell disease","volume":"148","author":"Brawley","year":"2008","journal-title":"Ann Intern Med"},{"issue":"2","key":"2019111705204081700_B86","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.hemonc.2014.03.001","article-title":"Leukemia during pregnancy: long term follow up of 32 cases from a single institution","volume":"7","author":"Saleh","year":"2014","journal-title":"Hematol Oncol Stem Cell Ther"},{"issue":"10","key":"2019111705204081700_B87","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/S0027-9684(15)31072-5","article-title":"Exposure to hydroxyurea and pregnancy outcomes in patients with sickle cell anemia","volume":"101","author":"Ballas","year":"2009","journal-title":"J Natl Med Assoc"},{"issue":"2","key":"2019111705204081700_B88","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1177\/0091270009343933","article-title":"Exposure to hydroxyurea during pregnancy in sickle-beta thalassemia: a report of 2 cases","volume":"50","author":"Italia","year":"2010","journal-title":"J Clin Pharmacol"}],"container-title":["Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/hematology\/article-pdf\/2014\/1\/418\/1250798\/bep00114000418.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/hematology\/article-pdf\/2014\/1\/418\/1250798\/bep00114000418.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,17]],"date-time":"2019-11-17T10:21:20Z","timestamp":1573986080000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/hematology\/article\/2014\/1\/418\/20500\/Reproductive-issues-in-sickle-cell-disease"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12,5]]},"references-count":88,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12,5]]}},"URL":"https:\/\/doi.org\/10.1182\/asheducation-2014.1.418","relation":{},"ISSN":["1520-4391","1520-4383"],"issn-type":[{"value":"1520-4391","type":"print"},{"value":"1520-4383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,12,5]]}}}